Clinical Trial Update: High-flow Nasal Cannula Nebulization of Beta 2 Adrenergic Agonist During Acute Exacerbation of Chronic Obstructive Pulmonary Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating nebulized beta-2 adrenergic agonist delivered through a high-flow nasal cannula during acute COPD exacerbations. The spon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: Poitiers University Hospital | Conditions: Chronic Obstructive Pulmonary Disease, High-flow Nasal Cannula | Phase 3 | Status: UNKNOWN